Vaximmune 20logo 20final 20jpg
Vaximmune 20logo 20final 20jpg


Vax-Immune’s LabReady® is a unique platform technology that improves the diagnosis of infection by moving the laboratory to the patient.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Houston, TX, USA
  • Currency USD
  • Founded June 2011
  • Employees 9
  • Incorporation Type LLC
  • Website

Company Summary

Vax-Immune’s LabReady® is a unique platform technology that improves infection diagnosis by moving the laboratory to the patient.

LabReady® strips out the inefficient time lapse between sample collection and diagnosis, resulting in faster, more accurate results, with better patient outcomes at lower costs.

LabReady® re-imagines the lab where everything happens before the sample arrives.


  • Default avatar
    Joaquin Altenberg
    Chief Financial Officer

    Mr. Altenberg: is a seasoned entrepreneur in biotechnology, technology and energy sectors; has grown companies in roles as CEO, CFO and business development; has secured over $3B in financing and served in investment or advisory positions with Salomon Smith Barney, Morgan Stanley, Citigroup, Lazard, and Vert Investment Group; has BSEE from University of Texas at Austin; has an MBA from Harvard Business School.

  • Default avatar
    Leonard E. Weisman
    President and Chief Technology Officer

    Dr. Weisman: is an inventor with prior development experience (Medimmune, Inc. sold for $15.6B in 2007, and Biosynexus, Inc secured $120M in venture capital); has been practicing neonatology and research for > 35 yrs; is Professor of Pediatrics at Baylor College of Medicine (260 publications, $15M in extramural research funding); has BS from USMA at West Point; has M.D. from Baylor College of Medicine; is retired U. S. Army colonel.

  • D6e21703 1665 4824 ac0d b9030e7cac73
    President and Chief Technology Officer

  • Default avatar
    Bhairavi Parikh, PhD
    Chief, Product Development Officer

    Dr. Parikh: is an experienced business woman with extensive expertise in medical diagnostics and women and children’s health; founded 3 companies including Apieron Biosystems, CellScape Corporation and CrestaBio, securing over $75M in financing; has a PhD in Biomedical Engineering from Worcester Polytechnic Institute and University Massachusetts Medical School.

  • 81795504 4e5e 41d9 a5e2 00160b2b09cd
    Chief, Business Development Officer

    Mr. von Brendel: is a dynamic leader of record breaking medical device sales and profit growth; has sales and marketing experience which includes: $150M sales with $60M profit, supervisory control of 1,600+ employees, taking an ophthalmic product from concept to market sales of $1B, and achieving #1 market share in the outside US heart valve market.